Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib Treatment [Phase 2]
Phase 2 trial update evaluating almonertinib in advanced non-small cell lung cancer patients with EGFR mutations who are safety intolerant a…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating fluzoparib combined with camrelizumab as maintenance therapy in locally advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 [Phase 1]
Phase 1 study evaluating Niraparib, TSR-022, Bevacizumab, and TSR-042 with platinum-based chemotherapy in patients with advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety [Phase 2, Phase 3]
Clinical trial update indicates JY025 is being studied as first-line treatment for EGFR-mutated non-small cell lung cancer in Phase 2 and Ph…
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Clinical trial update for nivolumab in advanced non-small cell lung cancer (Phase 1/2) completed with results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating toripalimab with platinum-based doublet for stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy [NA]
Phase I study update for accelerated hypofractionated image-guided radiation therapy in non-small cell lung cancer; trial completed with res…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases [Phase 3]
A Phase 3 trial comparing almonertinib to osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer with brain metastases…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Neoadjuvant Itraconazole in Non-small Cell Lung Cancer [EARLY_Phase 1]
Early-phase neoadjuvant trial evaluating itraconazole in non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer [Phase 2]
Clinical trial update for neoadjuvant chemotherapy with Tilelizumab in stage III non-small-cell lung cancer (Phase 2).
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy [Phase 2]
Phase 2 trial update of TAGRISSO (osimertinib) in NSCLC patients with T790M mutations detected by liquid biopsy.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC [Phase 3]
A Phase 3 neoadjuvant trial evaluating sintilimab plus platinum doublet chemotherapy for stage IIIA(N2) non-small cell lung cancer is report…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating efficacy and safety of MRG003 in EGFR-positive advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment [Phase 2]
Phase 2 trial assessing INC280 in combination with gefitinib for EGFR-mutated, c-MET-amplified non-small cell lung cancer after progression …
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating maintenance targeted therapy with or without stereotactic body radiation therapy in stage IV non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab with bevacizumab, nab-paclitaxel, and carboplatin for untreated metastatic pulmonary sarcomatoid carcin…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Phase 1/2 trial of mocetinostat with durvalumab in advanced solid tumors and NSCLC was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery [Phase 3]
Phase 3 trial evaluating perioperative bronchodilator use in COPD patients undergoing lung cancer surgery; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI [Phase 2]
Phase 2 trial update investigating neurocognition in NSCLC patients treated with osimertinib or osimertinib plus whole-brain irradiation (WB…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC [Phase 3]
Phase 3 trial comparing lorlatinib versus crizotinib in first-line ALK-positive non-small cell lung cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer [Phase 2]
Phase 2 study comparing EC145 alone, EC145 plus docetaxel, and docetaxel alone for second-line non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion [Phase 4]
Clinical trial update evaluating afatinib for NRG1 fusion–positive non-small cell lung cancer in a Phase 4 study.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing MB02 to Avastin in stage IIIB/IV non-squamous non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: MK-3475 in Melanoma and NSCLC Patients With Brain Metastases [Phase 2]
Phase 2 trial update for MK-3475 (pembrolizumab) in melanoma and non-small cell lung cancer patients with brain metastases has completed wit…